GTC Biotherapeutics (fka GTCB)

[raistthemage]

"New management would most likely cause a more rapid decline"

I cannot see how any reasonable person can not see what must be done here. Cox clearly has no business plan beyond diluting the stockholders (which is why even from an equity perspective the reverse split should be rejected) and will not implement the austerity measures (IMO putting everything but Atryn in stasis for now) needed to save the company. All the while him and the rest of useless management staff account for 10% of the burn rate. His PR's have also been generally been complete disasters since he doesn't follow through.

Hes chairman of the board (not CEO) of some other company called NABI which has declined steeply since he took over which gives further evidence the problem is mostly with Cox and his management team.